What drug is pomalidomide? What are its main ingredients and functions?

Pomalidomide (Pomalidomide) is an immunomodulatory drug that belongs to the class of immunomodulators (IMiDs). It is mainly used to treat multiple myeloma (MM), especially in patients who have failed at least one previous treatment. It is a derivative of thalidomide (Thalidomide) and has similar immunomodulatory effects, but its pharmacological properties and side effects are different, so it has certain advantages in terms of therapeutic effects and indications.

The main component of pomalidomide is pomalidomide itself, and its mechanism of action involves regulating the immune system and inhibiting the growth of tumor cells through multiple pathways. Specifically, pomalidomide promotes the immune escape process of tumor cells and enhances the anti-tumor immune response by increasing the activity of T cells and natural killer cells. At the same time, it can also inhibit angiogenesis in the bone marrow microenvironment, limit tumor blood supply, and further slow down the growth of cancer cells. In addition, pomalidomide promotes cancer cell apoptosis by inhibiting proteasomal degradation of tumor cells, further enhancing the anti-tumor effect.

Pomalidomide is commonly used to treat relapsed or refractory multiple myeloma, especially in patients who have failed to respond to immunomodulators such as lenalidomide and proteasome inhibitors such as bortezomib. It is often used in combination with dexamethasone (Dexamethasone) to form a standard treatment regimen to enhance the therapeutic effect. Studies have shown that pomalidomide, when used in combination with dexamethasone, can significantly improve patients' overall response rate and progression-free survival.

Although pomalidomide has significant efficacy, its use is also associated with certain side effects. Common adverse reactions include anemia, leukopenia, thrombosis, infection, fatigue, etc. In particular, the risk of thrombosis is high, so during treatment, patients need to use anticoagulant drugs under the guidance of a doctor and regularly monitor blood indicators. In addition, the use of pomalidomide is also subject to severe reproductive toxicity warnings and is absolutely contraindicated in pregnant women. Therefore, strict contraceptive measures are required when using it. Overall, pomalidomide plays an important role in the treatment of multiple myeloma, but it needs to be used under strict medical supervision to ensure safety and efficacy.

Reference materials:https://en.wikipedia.org/wiki/Pomalidomide